Medicalsystem Biotechnology Co., Ltd (SHE:300439)

SHE:300439 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Net Income	67.92	63.2	258	256.55	198.53	179.49
Depreciation & Amortization	173.55	163.26	210.21	169.63	191.67	194.82
Other Amortization	15.29	22.61	12.65	15.11	19.97	33.12
Loss (Gain) From Sale of Assets	-1.65	-1.66	0.67	0.78	0.32	-0.48
Asset Writedown & Restructuring Costs	0.7	0.3	2.2	10.87	13.1	4.03
Loss (Gain) From Sale of Investments	-3.83	3.3	-3.34	-11.33	5.98	15.98
Provision & Write-off of Bad Debts	5.3	5.3	-19.73	-4.28	40.98	21.85
Other Operating Activities	24.43	22.84	15.18	-6.86	41.69	48.81
Change in Accounts Receivable	-71.54	-64.04	16.71	206.66	-76.76	-147.18
Change in Inventory	2.8	33.85	-33.6	-58.02	-20.71	15.31
Change in Accounts Payable	28.42	41.61	-67.18	34.98	179.33	159.07
Change in Other Net Operating Assets	8.09	7.13	13.33	16.57	-19.2	-0.73
Operating Cash Flow	232.91	266.61	397.81	633.53	564.67	515.48
Operating Cash Flow Growth	-40.83%	-32.98%	-37.21%	12.20%	9.54%	-43.48%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Capital Expenditures	-151.71	-191.41	-420.54	-280.37	-303.13	-201.82
Sale of Property, Plant & Equipment	4.64	5.19	34.32	23.45	7.31	27.13
Divestitures	0.75	0.36	23.97	63.66	33.55	5.2
Investment in Securities	-225.12	-93.72	-183.79	18.81	21.13	-47.35
Other Investing Activities	9.52	21.22	18.93	12.38	8.66	29.27
Investing Cash Flow	-361.92	-258.35	-527.11	-162.08	-232.49	-187.56

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Short-Term Debt Issued	-	34.84	30	50	-	1.5
Long-Term Debt Issued	-	-	-	-	212.65	410.95
Total Debt Issued	94.84	34.84	30	50	212.65	412.45
Short-Term Debt Repaid	-	-45	-57.04	-278.04	-	-1.5
Long-Term Debt Repaid	-	-15.69	-16.84	-18.57	-383.19	-883.43
Total Debt Repaid	-42.95	-60.69	-73.88	-296.61	-383.19	-884.93
Net Debt Issued (Repaid)	51.89	-25.84	-43.88	-246.61	-170.55	-472.49
Issuance of Common Stock	2.21	2.21	-	-	-	586.6
Common Dividends Paid	-29.17	-51.99	-52.47	-49.88	-50.71	-91.39
Other Financing Activities	-12.68	-1.09	-0.06	-7.04	0.18	1.47
Financing Cash Flow	12.26	-76.71	-96.42	-303.52	-221.07	24.2

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Foreign Exchange Rate Adjustments	-0.86	-0.73	0.01	0.54	-1.58	0.93
Net Cash Flow	-117.61	-69.18	-225.71	168.47	109.52	353.06

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Free Cash Flow	81.2	75.21	-22.73	353.16	261.53	313.67
Free Cash Flow Growth	330.48%	-	-	35.04%	-16.62%	-40.66%
Free Cash Flow Margin	4.98%	4.89%	-1.30%	18.73%	10.51%	13.93%
Free Cash Flow Per Share	0.20	0.19	-0.06	0.92	0.69	0.84
Levered Free Cash Flow	9.11	-25.06	-46.86	238.63	138.27	245.86
Unlevered Free Cash Flow	10.48	-23.46	-45.28	245.29	148.04	264.15

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Cash Income Tax Paid	85.42	89.86	98.26	132.25	129.64	128.04
Change in Working Capital	-48.8	-12.54	-78.02	203.05	52.41	17.87

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error